CVN-424: Cerevance's Lead Therapeutic - A First-in-Class, Oral, Non-Dopaminergic Compound acting on a Novel Target (GPR6) - Market Size, Forecast, and Emerging Insights for 7MM 2019-2032
April 05, 2024 08:59 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "CVN-424 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
INBRIJA: A Dry Powder Formulation of Levodopa for Oral Inhalation with Inhaler - Market Size, Forecast, and Market Insights for 7MM 2019-2032
April 05, 2024 08:57 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "INBRIJA Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
NOURIANZ Market Size, Forecast, and Market Insight - 2032
April 05, 2024 08:55 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "NOURIANZ Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
ABBV-951 for Parkinson's Disease: An Investigational Drug-Containing Foslevodopa/Foscarbidopa Being Developed by AbbVie - Market Size, Forecast, and Market Insights to 2032
April 05, 2024 08:52 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "ABBV-951 Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This "report provides...
Global Parkinson Disease Market Projected to Reach $8.8 Billion by 2030, Driven by Advancements and Growing Demand for Effective Treatments
March 28, 2024 11:41 ET
|
Research and Markets
Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "Parkinson Disease Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Neurodegenerative Disease Market Report 2023: Sector is Expected to Reach $52.7 Billion by 2030 at a CAGR of 3.2%
May 25, 2023 12:28 ET
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Neurodegenerative Disease Market, By Indication Type, By Drug Type, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030"...
Multiple System Atrophy (MSA) - Market Insight, Epidemiology And Market Forecast 2023-2032
April 05, 2023 06:03 ET
|
Research and Markets
Dublin, April 05, 2023 (GLOBE NEWSWIRE) -- The "Multiple System Atrophy (MSA) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
2021 U.S. Parkinson's Disease Epidemiology Report: 10-year Forecasts of Parkinson's Disease Epidemiology
August 23, 2021 04:18 ET
|
Research and Markets
Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease - US Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. The report delivers an...
Global Parkinson's Disease Drug Forecast Report 2021-2029, Featuring Teva, Roche, Prothena, UCB, AbbVie and Norvartis
April 27, 2021 06:28 ET
|
Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The global PD...
Global Lewy Body Dementia Treatment Market (2020 to 2027) - Share, Size, Trends, Industry Analysis Report
March 19, 2021 08:03 ET
|
Research and Markets
Dublin, March 19, 2021 (GLOBE NEWSWIRE) -- The "Lewy Body Dementia Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Indication; By Distribution Channel; By Regions...